The impact of fractional exhaled nitric oxide (FeNO) measurement on treatment decision making in the specialist care of established asthma Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013
Clinical utility of exhaled nitric oxide fraction in the management of asthma and COPD Source: Breathe, 15 (4) 306; 10.1183/20734735.0268-2019 Year: 2019
Clinical utility of fractional exhaled nitric oxide in severe asthma management Source: Eur Respir J, 55 (3) 1901633; 10.1183/13993003.01633-2019 Year: 2020
Using fractional exhaled nitric oxide to guide step-down treatment decisions in asthma: practical considerations Source: Eur Respir J, 56 (2) 2002809; 10.1183/13993003.02809-2020 Year: 2020
Does treatment guided by exhaled nitric oxide fraction improve outcomes in subgroups of children with asthma? Source: Eur Respir J, 55 (5) 1901879; 10.1183/13993003.01879-2019 Year: 2020
The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015
Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Predictive value of exhaled nitric oxide in the management of asthma: a systematic review Source: Eur Respir J 2016; 48: 706-714 Year: 2016
Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016
Exhaled nitric oxide variations during oral challenge with different NSAIDs in patients with aspirin-induced asthma Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016
Opinions towards the implementation of spirometry and exhaled nitric oxide testing in children under investigation for asthma in primary care Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018
Does the measurement of exhaled nitric oxide before and after specific inhalation challenges improve the diagnosis of occupational asthma? Source: International Congress 2019 – Occupational lung diseases: from diagnostic techniques to classical and novel causes Year: 2019
Accuracy of exhaled nitric oxide to predict a loss of asthma control in well-controlled patients Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
The clinical utility of exhaled nitric oxide (eNO) in asthma, the first 1,000 patients Source: Eur Respir J 2004; 24: Suppl. 48, 304s Year: 2004
Usefulness of fraction of exhaled nitric oxide and asthma management questionnaires in predicting a future risk of asthma exacerbation Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019
Exhaled nitric oxide measurement as a diagnostic tool for asthma in a general allergy clinic Source: Annual Congress 2008 - Understanding airway inflammation Year: 2008
Experiences of exhaled nitric oxide measurements in diagnostics of occupational asthma Source: Eur Respir J 2001; 18: Suppl. 33, 281s Year: 2001
Ambulatory monitoring of exhaled nitric oxide in childhood asthma exacerbation Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008
Exhaled nitric oxide and clinical phenotype of childhood asthma Source: Annual Congress 2011 - Inflammation and genes in childhood asthma Year: 2011